Pulmonary Fibrosis

Pulmonary Fibrosis Treatment

Pulmonary fibrosis treatment

Cellular Therapy for Pulmonary Fibrosis

For doctors treating people living with pulmonary fibrosis, the goal of treatment is to slow the decline of lung function, relieve breathing difficulties caused by lung scarring and encourage the best possible quality of life. Traditional approaches include anti-inflammatory medications, oxygen therapy and pulmonary rehabilitation. However, because each patient and condition is unique, the effectiveness of these treatments can vary widely.

The Lung Institute offers cellular therapy as an alternative pulmonary fibrosis treatment. By harnessing the power of adult cells, this groundbreaking therapy may promote healing and improve lung function.  As such, cellular therapy provides a new source of hope for some people who are seeking treatment for pulmonary fibrosis, many of whom rely on supplemental oxygen around the clock or face challenges in performing everyday tasks.

At the Lung Institute, patient safety and comfort are paramount. Our treatments are patient-centered, and they are designed and administered accordingly. We perform minimally invasive procedures on an outpatient basis. The entire process takes place within a few hours during two consecutive days at our state-of-the-art facility. During cellular therapy for pulmonary fibrosis, our caring medical staff:

  • Harvests cells from a patient’s own blood
  • Separates the cells in an onsite lab
  • Reintroduces the cells into the patient’s body intravenously

At that point, the cells can travel through the bloodstream to reach the lungs, where they may begin to reduce inflammation and promote the natural healing process of damaged tissue. Because the cells are derived from the patient’s own body, the risks of rejection and other complications are virtually eliminated. More than 80 percent of people who undergo cellular therapy at the Lung Institute have reported an improvement in their quality of life.

The Lung Institute is proud to be a world-recognized leader in regenerative medicine and research. The progress we’ve made to date allows us to provide our patients with an alternative pulmonary fibrosis treatment that can potentially improve their lung function and enhance their quality of life. If you are exploring treatment options for pulmonary fibrosis, you are encouraged to consider the Lung Institute. For more information on cellular therapy for pulmonary fibrosis treatment, contact us at 888-745-6697.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.